|
|
Title | Last Updated |
A "State-of-the-Art" Conference on Hepatitis C |
May 6, 2008
|
A Case Study Approach to the Clinician's Challenge in Preserving Long-term Renal Function, Implication of Preserving Long-term Renal Function After Renal Transplantation, NIAID, NIH, DHHS |
Oct. 25, 2007
|
A Deadly Synergy, Tuberculosis (TB), NIAID, NIH |
April 1, 2005
|
A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors |
July 9, 1996
|
A Framework for Progress on Hepatitis C |
May 6, 2008
|
A Global Threat, Leishmaniasis, NIAID, NIH |
Aug. 11, 2008
|
A Killer Returns: The Face of the Epidemic, Tuberculosis, NIAID, NIH |
April 1, 2005
|
A Leading Cause of Blindness May Be Controlled by Simple Course of Oral Antibiotic |
Aug. 19, 1999
|
A Microbe Hunter On Call to the World, Discovery News, NIAID, NIH |
May 9, 2008
|
A Multiple-reach Model Describing the Migratory Behavior of Snake River Yearling Chinook Salmon (Oncorhynchus tshawytscha), Can. J. Fish. Aquat. Sci. 55, 1998 |
Aug. 6, 2007
|
A New Registry for Primary Immune Deficiency Diseases |
Oct. 30, 1997
|
A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers, NIAID |
May 7, 2001
|
A Phase IIB randomized, controlled trial to evaluate the safety, tolerance, and HIV vertical transmission rates associated with short course nevirapine (NVP) vs. short course zidovudine (ZDV) in HIV infected pregnant women and their infants in Uganda |
July 15, 1999
|
A Potential New Target for Treating Asthma, NIAID, NIH |
Dec. 1, 2006
|
A Risky Business, Anthony S. Fauci, Washington Times, November 30, 2004 |
Aug. 6, 2007
|
A Safety Evaluation of MDCK for Influenza Vaccine Production, Vaccine Cell Substrate 2004, Practical Experience |
April 11, 2008
|
A Small Genetic Change Makes Flu Virus Deadly |
Sept. 6, 2001
|
A Timely Test: Real Time PCR, Tuberculosis (TB), NIAID, NIH |
April 1, 2005
|
A view from Washington through the eyes of an AAP physician-scientist, Anthony Fauci, Journal of Clinical Investigation, October 2007 |
Dec. 26, 2007
|
Abnormal Immune Cells May Cause Unprovoked Anaphylaxis |
Nov. 13, 2007
|
About CMB, Comparative Medicine Branch |
July 6, 2006
|
About NIAID |
June 14, 2005
|
About NIAID Labs |
March 13, 2007
|
About the DAIDS Clinical Research Policies and Standard Procedures Documents, NIAID, NIH |
Nov. 28, 2007
|
About the DMID Office of Clinical Research Affairs (OCRA), NIAID, NIH |
April 19, 2007
|
About the Research Technologies Branch, NIAID, NIH |
Sept. 5, 2006
|
About the TB Bug, Tuberculosis, NIAID, NIH |
April 1, 2005
|
About, NIAID HIV and Emerging Infectious Diseases Program, NIAID, NIH |
Oct. 17, 2006
|
Abstract: “Enteric Vaccines for Pediatric Use” Workshop Report, April 24-26, 2004, NIAID, NIH |
Aug. 6, 2007
|
Abstract: “Hit” to Clinical Candidate: Discovery and Characterization of the Aminomethylcyclines |
Sept. 7, 2007
|
Abstract: Antiviral Drug Development for Biothreat Agents, Tove C. Bolken, Head of Research Operations, SIGA Technologies, Inc. |
Sept. 7, 2007
|
Abstract: Bacillus anthracis Antimicrobials Derived from Inhibitors of Mammalian Serine-Threonine Kinases, Jimmy D. Ballard, Ph.D. |
Sept. 7, 2007
|
Abstract: Challenges of Antibiotic Drug Development in the 21st Century, Karen Bush, Ph. D., |
Sept. 7, 2007
|
Abstract: Chop-lump Tests for Vaccine Trials, September 4, 2007 |
Sept. 20, 2007
|
Abstract: Combining Focused Antisense Screening Technology (FAST) and Structure-based Drug Design (SBDD) for Antibacterial Discovery |
Sept. 7, 2007
|
Abstract: Development of Antiviral RNA Interference Therapeutics, Antonin de Fougerolles |
Sept. 7, 2007
|
Abstract: Development of Cysteine Cathepsin Inhibitors as Anti-Ebola Virus Agents - James M. Cunningham |
Sept. 7, 2007
|
Abstract: Discovery of Smallpox Inhibitors that Block Processive DNA Synthesis |
Sept. 7, 2007
|
Abstract: Dose and Schedule Choices to Suppress Emergence of Resistance G.L. Drusano, M.D., Ordway Research Institute |
Sept. 7, 2007
|
Abstract: Efflux Pump Inhibitors: from Tools to Drugs |
Sept. 7, 2007
|
Abstract: Identification of Inhibitors of Ebola Virus Using a Subgenomic Replication System |
Sept. 7, 2007
|
Abstract: Identification of Small Molecule Inhibitors of Anthrax Lethal Factor |
Sept. 7, 2007
|
Abstract: Impact of Drug-Like Properties on Hit Selection and Optimization for Quality Clinical Candidates |
Sept. 7, 2007
|
Abstract: Leveraging Structure-Based Drug Design Technologies to Accelerate Drug Candidate Generation |
Sept. 7, 2007
|
Abstract: Multi-target Anthrax Antitoxin Therapies, February 7, 2007 |
Sept. 7, 2007
|
Abstract: Nucleotides as Anti-HBV Agents, R. P. Iyer, Ph.D. |
Sept. 7, 2007
|
Abstract: Old Target, New Approach: Developing Pterin-like Small Molecules as Inhibitors of the Bacterial Folate Pathway |
Sept. 7, 2007
|
Abstract: Optimizing the Oral Bioavailability and Activity of Antiviral Drugs, Karl Y. Hostetler |
Sept. 7, 2007
|
Abstract: Pitfalls of Target Validation for Novel Antibacterial Strategies, David J. Payne |
Sept. 7, 2007
|
Abstract: The Discovery of Orally Active Inhibitors of Respiratory Syncytial Virus, Nicholas A. Meanwell |
Sept. 7, 2007
|
Abstract: Use of a Cocktail to Reduce the Need for Drug Interaction Studies During Drug Development - Joseph S. Bertino Jr., Pharm.D., FCP |
Sept. 7, 2007
|
Acellular Pertussis Vaccine Proves Effective in Adults, Adolescents |
Oct. 12, 2005
|
Achievements and Goals, Chemical Countermeasures, NIAID, NIH |
March 3, 2008
|
Achieving and Maintaining Polio Eradication, Polio Immunization: Moving Forward, September 19-20, 2007 |
Dec. 26, 2007
|
Acquired Immunodeficiency Review Committee, About NIAID, NIAID, NIH |
July 22, 2004
|
Acquired Immunodeficiency Syndrome (AIDS) Panel, US-Japan Cooperative Medical Science Program, NIAID, NIH |
Nov. 16, 2007
|
Acquired Immunodeficiency Syndrome (AIDS), Selected Scientific Areas of Research |
Dec. 23, 2004
|
Acronyms, Comparative Medicine Branch |
July 2, 2006
|
ACTG 175, CPCRA 007 Trial Results Published |
Oct. 9, 1996
|
ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS |
Sept. 14, 1995
|
ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function |
Jan. 26, 1997
|
Actividades del Día de Concientización Sobre la Vacuna Contra el VIH/SIDA, 18 de mayo del 2005 |
July 30, 2007
|
Actividades del Día de Concientización Sobre las Vacunas Contra el VIH 18 de Mayo del 2006 |
July 30, 2007
|
Acute Respiratory Infections Panel, US-Japan Cooperative Medical Science Program, NIAID, NIH |
March 10, 2005
|
Adaptively Changing Subgroup Proportions in Clinical Trials, Dean Follman, Statistica Sinica 1997 |
July 25, 2007
|
Add Your Voice, Division of AIDS (DAIDS), NIAID, NIH |
Sept. 11, 2008
|
Add Your Voice: Opportunties for Community Participation in HIV/AIDS Research, DAIDS, NIAID, NIH |
July 30, 2007
|
Adding IL-2 to Potent Anti-HIV Drugs Increases CD4+ T-Cell Counts Without Raising HIV Levels |
July 8, 2000
|
Additional Questions and Answers to RFP NIH-NIAID-DMID-PR2004-01 ‘Neutralizing Monoclonal Antibodies Type A for Botulinum Neurotoxins’ |
Sept. 12, 2007
|
Additional Questions and Answers to the RFP No. NIH-NIAID-DMID-PR2004-02, ‘Recombinant Type E Botulinum Neurotoxin Vaccine’ |
Sept. 12, 2007
|
Additional Resources, HIV/AIDS Specimen Repository |
May 15, 2008
|
Additional Resources, New Investigator Workshot, DAIT, NIAID, NIH |
Nov. 7, 2007
|
Addressing Antimicrobial Resistance, Slide 7, Testimony of Dr. Fauci, February 25, 1999 |
Feb. 24, 1999
|
Addressing Health Disparities: NIAID Agenda, Slide 9, Dr. Anthony S. Fauci, March 1, 2000 |
March 1, 2000
|
Adenovirus Potency Assays: Novel Approaches to Current Challenges |
April 11, 2008
|
Adjournment, National Advisory Allergy and Infectious Diseases Council January 2005 Minutes |
March 15, 2005
|
Adjournment, National Advisory Allergy and Infectious Diseases Council September 1997 Minutes |
March 13, 2001
|
Adjournment, National Advisory Allergy and Infectious Diseases Council: February 2000 Minutes |
March 2, 2001
|
Adjournment, National Advisory Allergy and Infectious Diseases Council: September 1998 Minutes |
March 12, 2001
|
Adjuvants and Other Vaccine Ingredients, Vaccines, NIAID, NIH |
Sept. 4, 2008
|
Adriana Marques, M.D., Clinical Studies Unit, Laboratory of Clinical Infectious Diseases, NIAID, NIH |
June 13, 2008
|
Adult Male Circumcision Reduces Risk of HIV Acquisition for at Least 3.5 Years |
Aug. 11, 2008
|
Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early |
Dec. 13, 2006
|
Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early |
Dec. 13, 2006
|
Advanced Product Development for Multiplex Infectious Disease Diagnostics: Summary of a NIAID Workshop |
Aug. 6, 2007
|
Advances in AIDS Pathogenesis and Preclinical Vaccine Development |
April 29, 1997
|
Advances in Treatment, Flu (Influenza), NIAID, NIH |
Nov. 28, 2006
|
Advances in Treatment, Tuberculosis (TB), NIAID, NIH |
July 17, 2008
|
Adventitious Virus Tests, Vaccine Cell Substrates 2004, June 30, 2004 |
April 11, 2008
|
Advisory and Working Groups, HIV/AIDS Vaccines, NIAID, NIH |
Sept. 12, 2007
|
Aedes Aegypti Announcement, October 2005, Pathogen Genomics, Research, NIAID, NIH |
Jan. 5, 2006
|
Aedes Announcement, June, Pathogen Genomics, Research, NIAID, NIH |
July 26, 2006
|
Aerosol Challenge Technology and Applications in Biodefense “Biological Safety” |
Sept. 12, 2007
|
Aerosol Challenge Technology and Applications in Biodefense, Biodefense, NIAID, NIH |
Feb. 7, 2007
|
Aerosol delivery of MTB and Chemotherapeutics: Pitfalls and Plans, Laura E. Via, Ph.D. |
Sept. 12, 2007
|
Aerosol Generation |
Sept. 12, 2007
|
Aerosol Parameters (Historical) |
Sept. 12, 2007
|
Aerosolized filoviruses in three species of nonhuman primates: Differences in disease course and pathology |
Dec. 26, 2007
|
Africa Malaria Day and Malaria Awareness Day, April 25, 2007, NIAID, NIH |
April 25, 2007
|
Africa, Global Research, NIAID, NIH |
Sept. 15, 2008
|
African Americans Inspiring Hope |
May 17, 2005
|
African Americans: Answers about HIV Vaccine Research, NIAID, NIH |
Sept. 11, 2008
|
Age of Optimism, Tuberculosis (TB), NIAID, NIH |
Feb. 28, 2006
|
Age-Based Screening is Cost-Effective Method to Control Chlamydial Infection |
Feb. 17, 1998
|
Agenda - OPV |
Dec. 26, 2007
|
Agenda, 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program, NIAID, NIH |
July 25, 2007
|
Agenda, Mycobacteria Symposium, NIAID, NIH |
Sept. 3, 2008
|
Agenda, Pediatric Tuberculosis Meeting, NIAID, NIH |
June 3, 2008
|
Agenda, Polio Immunization: Moving Forward, September 19-20, 2007, NIH |
Aug. 1, 2007
|
Agenda, Vaccines for Viral Infections in Developing Countries |
Aug. 2, 2006
|
Agenda: 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program |
Aug. 6, 2007
|
Agenda: Medical Countermeasures against Combined Injury: Radiation with Burn, Blast, Trauma and/or Sepsis, March 26 - 27, 2007 |
Aug. 6, 2007
|
Agenda: Prevention of Group A Streptococcal Diseases and Their Sequelae |
Aug. 16, 2007
|
Agricultural Workers at Increased Risk for Infection with Animal Flu Viruses |
Nov. 25, 2005
|
AIDS Care in Africa Meeting, Kampala, Uganda, April 18-20, 2001, Slide 18, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
AIDS Clinical Trials Group: Affiliated Clinical Trials Units and Clinical Research Sites |
July 24, 2007
|
AIDS Deaths in the United Stated: January 1985-June 1997, Slide 4, Dr. Anthony S. Fauci, September 16, 1998 |
Jan. 14, 1999
|
AIDS Deaths in the United States, 1/86-9/98, Slide 4, Dr. Anthony S. Fauci, July 9, 1999 |
July 16, 1999
|
AIDS Deaths in the United States, 1985-2000, Slide 20, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
AIDS Deaths in the United States, January 1986 - June 1998, Slide 2, Dr. Anthony S. Fauci, 1999 |
March 5, 1999
|
AIDS Deaths in the United States: January 1985-June 1997, Poster 2 |
Jan. 18, 2005
|
AIDS Deaths in the United States: January 1985-June 1997, Slide 1, Dr. Anthony S. Fauci, March 18, 1998 |
Jan. 15, 1999
|
AIDS Drugs Have Saved 3 Million Years of Life in the United States |
June 2, 2006
|
AIDS Research Advisory Committe, NIAID, NIH |
May 28, 2008
|
AIDS Research and Prevention, Slide 8, Dr. Anthony S. Fauci, September 16, 1998 |
Jan. 14, 1999
|
AIDS Research, Slide 10, Dr. Anthony S. Fauci, July 9, 1999 |
July 16, 1999
|
AIDS Vaccine 2007 Report |
Jan. 8, 2008
|
AIDS Vaccine Research Highlights |
July 8, 1996
|
AIDS Vaccine Research Subcommittee (AVRS), Dec 2007, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH |
June 23, 2008
|
AIDS Vaccine Research Subcommittee (AVRS), May 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH |
July 17, 2008
|
AIDS Vaccine Research Working Group (AVRWG) |
Sept. 11, 2008
|
AIDS Vaccine Research Working Group (AVRWG) Committee Members, NIAID, NIH |
Dec. 14, 2007
|
AIDS Vaccine Research Working Group Archived Meeting Summaries, NIAID, NIH |
Oct. 18, 2007
|
AIDS Virus Reformatted to Shuttle Repair Genes to Diseased Brains |
April 11, 1996
|
Airborne Allergies: Something in the Air |
Feb. 12, 2008
|
Alan Sher, Immunobiology Section, Laboratory of Parasitic Diseases, NIAID, NIH |
Feb. 4, 2008
|
Alasdair M. Gilfillan, Ph.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH |
July 8, 2008
|
Albert Z. Kapikian, M.D., Epidemiology Section, Laboratory of Infectious Diseases, NIAID, NIH |
May 22, 2006
|
Alfonso Gozalo, D.V.M., M.S., Veterinary Care, Comparative Medicine Branch, NIAID, NIH |
June 27, 2006
|
Alison McBride Ph.D., DNA Tumor Virus Section, Laboratory of Viral Diseases, NIAID, NIH |
Sept. 19, 2008
|
Allergic Diseases, NIAID, NIH |
April 24, 2008
|
Allergy / Immunology Fellowship Application Process, NIAID, NIH |
Dec. 26, 2007
|
Allergy and Immunology Training Program in the Division of Intramural Research (DIR), NIAID, NIH |
Nov. 13, 2006
|
Allergy News Releases, NIAID, NIH |
June 30, 2008
|
Allergy, Immunology, and Transplantation Research Committee, About NIAID, NIAID, NIH |
March 9, 2005
|
Alsner.pdf |
April 9, 2008
|
Alteration in Cell Death Pathway Sheds Light on Autoimmune Disease |
July 8, 1999
|
Amendment #1 (Questions and Answers) to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” |
Sept. 12, 2007
|
Amendment #1 (Questions and Answers) to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" |
Sept. 12, 2007
|
Amendment #1 to RFP NIH-NIAID-DMID-03-54, “Construction Quality Management (CQM) Support Services” |
Sept. 12, 2007
|
Amendment #1 to RFP-NIH-NIAID-DAIT-04-38 |
Sept. 12, 2007
|
Amendment #1 to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" |
Sept. 12, 2007
|
Amendment #1 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” |
Sept. 12, 2007
|
Amendment #1 to RFP-NIH-NIAID-DMID-03-45, "Administrative Resource for Biodefense Proteomic Centers" |
Sept. 12, 2007
|
Amendment #1, RFP NIH-NIAID-DMID-04-40, In Vitro and Animal Models for Emerging Diseases and BioDefense |
Sept. 12, 2007
|
Amendment #2 (Questions and Answers) to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" |
Sept. 12, 2007
|
Amendment #2 to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” |
Sept. 12, 2007
|
Amendment #2 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” |
Sept. 12, 2007
|
Amendment #2 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” |
Sept. 12, 2007
|
Amendment #2 to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" |
Sept. 12, 2007
|
Amendment #3 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” |
Sept. 12, 2007
|
Amendment #3 to RFP-NIH-NIAID-DMID 04-34 |
Sept. 12, 2007
|
Amendment #3 to RFP-NIH-NIAID-DMID-03-29 |
Sept. 12, 2007
|
Amendment #4 to RFP NIH-NIAID-DMID-BAA-03-38 |
Sept. 12, 2007
|
Amendment #4, to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” |
Sept. 12, 2007
|
Amendment #5 to RFP NIH-NIAID-DMID-BAA-03-38 |
Sept. 12, 2007
|
Amendment of NIAID Solicitation RFP NIH-NIAID-DMID-03-39, "In vitro and Animal Models for Emerging Diseases and Biodefense" |
Sept. 12, 2007
|
Amino Acid Analysis and Conjugation Efficiency Assays, Technology, Peptide Synthesis, Research Technologies Branch, NIAID, NIH |
May 15, 2008
|
Amphipathic Oral Chelators and Radionuclide Contamination |
Dec. 26, 2007
|
An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States |
July 20, 2007
|
An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 |
Aug. 6, 2007
|
An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 |
April 11, 2008
|
An HIV/AIDS Research Agenda in Developing Countries must be:, Slide 3, Dr. Esparza, July 7, 2001 |
July 6, 2001
|
An Ontological Representation of Complex Immunological Networks (Computing with Biological Knowledge) - Lindsay G. Cowell, Duke University Center for Computational Immunology |
July 24, 2007
|
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-interferon Alfa 2b Every Two Weeks with Ribavirin Among HIV/HCV Coinfected Individuals |
May 15, 2008
|
Analyses, Technology, Mass Spectrometry, Research Technologies Branch, NIAID, NIH |
March 21, 2007
|
Andreassen.pdf |
April 9, 2008
|
Animal Models for Experimental Therapeutics and Vaccines Application Process, Services, DMID, NIAID, NIH |
July 7, 2008
|
Animal Models for Experimental Therapeutics and Vaccines Assurances, Services, DMID, NIAID, NIH |
July 7, 2008
|
Animal Models for Experimental Therapeutics and Vaccines Eligibility, Services, DMID, NIAID, NIH |
July 7, 2008
|
Animal Models for Hepatitis B and C Application, Services, DMID, NIAID |
July 3, 2008
|
Animal Models for Hepatitis B and C Assurances, Services, DMID, NIAID |
July 2, 2008
|
Animal Models for Hepatitis B and C Eligibility, Services, DMID, NIAID |
July 2, 2008
|
Animal Models for Hepatitis B and C Review, Services, DMID, NIAID |
July 3, 2008
|
Animal Models for Hepatitis B and C, Services, DMID, NIAID |
July 14, 2008
|
Animal Models for the Evaluation of Experimental Therapeutics and Vaccines Review Process, Services, DMID, NIAID, NIH |
July 7, 2008
|
Animal Models for the Evaluation of Experimental Therapeutics and Vaccines, Services, DMID, NIAID, NIH |
July 14, 2008
|
Animal Models, HIV/AIDS Vaccine Research, NIAID, NIH |
June 21, 2006
|
Animal Rule II: CDER Perspective/Case Studies, NIAID Workshop on Aerosolization Technolgies, December 4, 2003 |
Sept. 12, 2007
|
Animal Studies, Vaccines, NIAID, NIH |
July 17, 2008
|
Ankara Awards, Biodefense, NIAID, NIH |
Dec. 20, 2006
|
Ankara Awards, Biodefense, NIAID, NIH |
Dec. 20, 2006
|
Announcement of Availability of Overlapping Peptides for Influenza Proteome, January 27, 2006, Public Health Service, DHHS |
Aug. 6, 2007
|
Announcement of Funds Available for Pilot Grants from the Fred Hutchinson Cancer Research Center/ University of Washington Center for Medical Countermeasures Against Radiation (CMCR) |
Aug. 6, 2007
|
Announcement of Funds Available for Pilot Grants from the Fred Hutchinson Cancer Research Center/ University of Washington Center for Medical Countermeasures Against Radiation (CMCR), December 21, 2005 |
Aug. 6, 2007
|
Annual Commemerative Days, NIAID, NIH |
May 16, 2008
|
Anthony Fauci '58, Regis Alumni News Winter |
July 27, 2007
|
Anthony S. Fauci Awarded 2001 Frank Annunzio Award |
Oct. 4, 2001
|
Anthony S. Fauci Awarded Lasker Award for Public Service |
Sept. 14, 2007
|
Anthony S. Fauci Awarded the Highest Honor of the Association of American Physicians, NIAID, NIH |
April 13, 2007
|
Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules |
Jan. 28, 1996
|
Anthony S. Fauci, M.D., Immunopathogenesis Section, Laboratory of Immunoregulation, NIAID, NIH |
May 12, 2008
|
Anthony S. Fauci, M.D., Lab Photo, 2007, NIAID, NIH |
April 13, 2007
|
Anthrax Awards, Biodefense, NIAID, NIH |
Dec. 20, 2006
|
Anthrax Genome Decoded |
April 30, 2003
|
Anthrax, NIAID, NIH |
Aug. 22, 2008
|
Antibiotic Therapy, Lyme Disease, NIAID, NIH |
Dec. 6, 2007
|
Antibodies Gone Awry, Multiple Sclerosis, NIAID, NIH |
Dec. 15, 2006
|
Antifungal Drug Helps Kids with Immune Disorder Avoid Hospitalization |
June 11, 2003
|
Antigen Research, Malaria Vaccine Development Branch, NIAID, NIH |
May 15, 2008
|
Antigenic Drift Illustration, How the Flu Virus Changes, Flu (Influenza), NIAID, NIH |
Dec. 4, 2006
|
Antigenic Drift vs. Antigenic Shift, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH |
Dec. 4, 2006
|
Antigenic Shift Illustration, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH |
Dec. 4, 2006
|
Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds |
Feb. 6, 2008
|
Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection |
Nov. 2, 1999
|
Antimicrobial (Drug) Resistance Research in NIAID Labs, NIH |
March 21, 2008
|
Antimicrobial (Drug) Resistance, NIAID, NIH |
June 16, 2008
|
Antimicrobial (Drug) Resistance: A Growing Health Issue, NIAID, NIH |
March 4, 2008
|
Antimicrobial Resistance - Selected Scientific Areas of Research |
Dec. 23, 2004
|
Antimicrobial Resistance News Releases, NIAID, NIH |
March 10, 2008
|
Antimicrobial Resistance: The NIH Response to a Growing Problem, Table of Contents, Dr. Anthony S. Fauci |
Feb. 23, 1999
|
Antimicrobial Resistance: The NIH Response to a Growing Problem. Statement of Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, February 25, 1999 |
Sept. 13, 1999
|
Antiretroviral Therapy (ART) to Reduce the Transmission of HIV, NIAID, NIH |
April 21, 2008
|
Antiviral Drug Development for Biothreat Agents - Tove Bolken, SIGA Technologies, Inc. |
Sept. 7, 2007
|
Appendices |
Aug. 6, 2007
|
Appendices |
July 26, 2007
|
Appendices - NIAID Profile FY 2003 |
Dec. 23, 2004
|
Appendix 1: DAIDS Guidance for Protocol Documents, NIAID, NIH |
Aug. 6, 2007
|
Appendix 1: Data Management Requirements for Data Collection Sites |
Aug. 6, 2007
|
Appendix 1: Essential Documents Recordkeeping Requirements |
Aug. 6, 2007
|
Appendix 1: Guidance on Study Monitoring Reports |
Aug. 6, 2007
|
Appendix 1: Required Site SOPS |
Aug. 6, 2007
|
Appendix 1: Source Documentation Requirements |
Aug. 6, 2007
|
Appendix 2: DAIDS Requirements for Non-U.S. Laboratories Guidance to Investigators Applying for Funding to Conduct HIV/AIDS Clinical Trials |
Aug. 6, 2007
|
Appendix 2: Data Management Requirements for Central Data Management Facilities |
Aug. 6, 2007
|
Appendix 2: Manual of Operations (MOP) Sample Table of Contents |
Aug. 6, 2007
|
Appendix 2: Study Progress and Safety Monitoring Plan Template |
Aug. 6, 2007
|
Appendix 3: Statistical Requirements |
Aug. 6, 2007
|
Appendix 6: DAIDS Independent Safetly Monitor (ISM) Guidelines |
Aug. 6, 2007
|
Appendix A 1 |
Oct. 9, 2007
|
Appendix A: Aerosol System Flow |
Oct. 9, 2007
|
Appendix A: Strategic Plan for Biodefense Research |
Sept. 7, 2007
|
Appendix B: Covered Sort Chamber |
Oct. 9, 2007
|
Appendix C: AeroTech Device |
Oct. 9, 2007
|
Appendix D: Position of the AeroTech Device |
Oct. 9, 2007
|
Appendix E: Glo-Germ |
Oct. 9, 2007
|
Appendix F: Collected Particles |
Oct. 9, 2007
|
Appendix G: Aerosol Cont. Report |
Oct. 9, 2007
|
Appendix H: Flow Lab Warning |
Oct. 9, 2007
|
Appendix I: Bio-Safety Suite |
Oct. 9, 2007
|
Appendix J: References |
Oct. 9, 2007
|
Application Information, Working at NIAID, NIH |
March 30, 2001
|
Application Process, Proteomics Research Centers, DMID, NIAID, NIH |
July 10, 2008
|
Application Process, Services for Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH |
June 20, 2008
|
Application Process, Summer Internship Program in Biomedical Research, OTSEP, NIAID, NIH |
July 13, 2006
|
Approach to the Development of an HIV Vaccine, Poster 24 |
Jan. 18, 1999
|
Approaches to HIV Prevention, Poster 6 |
Jan. 18, 1999
|
Approaches to HIV Prevention, Slide 27, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
Approaches to HIV Prevention, Slide 6, Dr. Anthony S. Fauci, September 16, 1998 |
Jan. 14, 1999
|
Approaches to HIV Prevention, Slide 7, Dr. Anthony S. Fauci, July 9, 1999 |
July 16, 1999
|
Approaches to Potency Assays of Pre-and Prepro-Biologic Vaccines: The Role of RT-PCR and Genetic Stability in Characterizing Potency of Plasmnid DNA-based Vaccines |
April 11, 2008
|
Approval Process, Proteomics Research Centers, DMID, NIAID, NIH |
July 14, 2008
|
Approved Anit-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, September 16, 1998 |
Jan. 14, 1999
|
Approved Anti-HIV Drugs, Slide 19, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
Approved Anti-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, July 9, 1999 |
July 16, 1999
|
Architectural Rendering, Building 33, NIAID, NIH |
May 1, 2006
|
Archive of Conferences and Meetings SummariesDivision of Allergy, Immunology, and Transplantation (DAIT), NIAID, NIH |
Aug. 9, 2005
|
Archive of NIAID in the News |
June 17, 2005
|
Arnold S. Kirshenbaum, M.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH |
March 22, 2005
|
Article in Press, K.-L. Nguyen et al., Virology 2004 |
Aug. 1, 2007
|
Articles & Multimedia, Biodefense, NIAID, NIH |
Dec. 18, 2006
|
Ascariasis, NIAID, NIH |
Aug. 1, 2008
|
Asexual Blood-Stage Vaccines, Malaria Vaccine Development Branch, NIAID, NIH |
May 15, 2008
|
Ashish Jain, M.D., Clinical Immunology Unit, Laboratory of Host Defenses, NIAID, NIH |
March 12, 2008
|
Assay Requirements |
April 11, 2008
|
Assaying Potency of Novel Vaccines |
April 10, 2008
|
Assays For An AAV Vectored HIV Vaccine |
April 11, 2008
|
Assays for Bovine Viruses |
April 11, 2008
|
Association of American Physicians Presidential Address: The AIDS Model: Scientific and Policy Lessons for the 21st Century, Anthony S. Fauci |
July 19, 2007
|
Assurances, Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH |
July 15, 2008
|
Asthma and Allergic Diseases, Selected Scientific Areas of Research |
Dec. 23, 2004
|
Asthma Facts, NIAID, NIH |
Sept. 3, 2008
|
Asthma News Releases |
Sept. 18, 2008
|
Asthma Research in NIAID Labs, NIAID, NIH |
April 29, 2008
|
Asthma Researchers Present New Results, New Perspectives on the Disease |
Feb. 25, 2002
|
Asthma, NIAID, NIH |
Sept. 19, 2008
|
Aton Pharma |
Dec. 26, 2007
|
Atopic Awards, Biodefense, NIAID, NIH |
Dec. 28, 2006
|
Attachment II: Safety Monitoring Committee (SMC) Guidelines, DMID, NIAID, NIH |
Aug. 6, 2007
|
Attachment III: Independent Safety Monitor (ISM) Guidelines, NIAID, NIH |
Aug. 6, 2007
|
Auchincloss Statement 10.4.07 |
May 12, 2008
|
Aug. 11, 2004 - Work on the Building Interior |
May 2, 2006
|
Augmented Designs to Assess Immune Response in Vaccine Trials |
Aug. 6, 2007
|
Australia, Western Pacific, Global Research, NIAID, NIH |
Nov. 9, 2007
|
Autoimmune Disease New Releases |
Aug. 13, 2008
|
Autoimmune Diseases - Selected Scientific Areas of Research |
Dec. 23, 2004
|
Autoimmune Diseases Research Plan, NIAID, NIH |
Sept. 14, 2007
|
Autoimmune Diseases, NIAID, NIH |
March 28, 2006
|
Autoimmune Lymphoproliferative Syndrome (ALPS), NIAID, NIH |
May 30, 2008
|
Autoimmune Reactivity, Lyme Disease, NIAID, NIH |
Dec. 6, 2007
|
Avian Influena - Pandemic Preparedness |
Dec. 26, 2007
|
AVRS May 2007 Summary |
Oct. 19, 2007
|
AVRSWorkshopAgendaSept2008.pdf |
Sept. 15, 2008
|
AVRWG Advice on Adenovirus Vectors, Jan 07, DAIDS, NIAID, NIH |
Aug. 6, 2007
|
AVRWG Workshop Summary, January 07, DAIDS, NIAID, NIH |
Aug. 6, 2007
|
Award Will Boost HIV/AIDS Research in China |
June 28, 2002
|
Awardees, Medical Countermeasures Against Radiological and Nuclear Threats, NIAID, NIH |
Oct. 5, 2007
|
Awards, Bioinformatics Resource Centers, NIAID, NIH |
Sept. 19, 2008
|
Awards, Centers of Excellence for Influenza Research and Surveillance, NIAID, NIH |
July 24, 2008
|
Awards, In Vitro and Animal Modules, Biodefense, NIAID, NIH |
March 10, 2008
|
Awards, Proteomics Research Centers, DMID, NIAID, NIH |
April 15, 2008
|
|
|
|
|
|